Policy

Susan Dentzer, Senior Policy Adviser, Robert Wood Johnson Foundation, says that there is growing interest in protecting healthcare providers from medical liability if they are following evidence-based protocols.

Patrick Gleason, PharmD, Director of Health Outcomes, Prime Therapeutics, says by 2017, 50% of all expenditures for drugs will be in the specialty drug space.

Accountable care organizations will be more successful in taking on accountability for patient outcomes when market and firm organization get a balanced treatment.

This study suggests that implementing a patient-centered medical home requires additional staff with specific expertise based on the needs of the practice and its population.

The state of Hawaii has mandated employer-based coverage since 1974, offering an opportunity for learning as implementation of the Affordable Care Act ramps up.

Could transparency in healthcare pricing decrease the disparity of costs in routine procedures?

Ongoing shortages of common oncology chemotherapies have compelled physicians to substitute more expensive drugs, delay or suspend clinical trials, or even skip doses of chemotherapy, according to survey results gathered by a team from the University of Pennsylvania.

Michael Kolodziej, MD, National Medical Director for Oncology Strategies, Aetna, says that in regard to payers impacting the use of immunotherapies, most payers have decided they will respect the judgment of the Food and Drug Administration, Centers for Medicare & Medicaid Services and the National Comprehensive Cancer Network.